Exploring Methylene Blue, Ozone, and UBI Therapy: Study Results from Oasis Family Medicine

Exploring Methylene Blue, Ozone, and UBI Therapy: Findings from Oasis Family Medicine

At Oasis Family Medicine, Dr. Yoshi Rahm and his team recently conducted a study investigating the combined effects of Ultraviolet Blood Irradiation (UBI), ozone, and methylene blue on overall health. This study, involving 40 participants, aimed to objectively assess the impact of these therapies on inflammation, immune function, and mitochondrial health. Here’s a look at the process, the findings, and what it means for the future of integrative IV therapies.

Study Overview and Purpose

The study included six intravenous (IV) sessions, each with different combinations of therapies. Dr. Rahm introduced light (UBI) therapy, ozone, and methylene blue to help improve immune support and reduce inflammation markers. Here’s a brief overview of each therapy component and its role:

• UBI Therapy (Ultraviolet Blood Irradiation): Using visible light, UBI therapy targets various pathogens while promoting immune function and reducing inflammation. This therapy includes the visible light spectrum (400-700 nm) and ultraviolet wavelengths, each benefiting different cellular processes.
• Ozone Therapy: Combining ozone (O3) and oxygen (O2), this therapy promotes red blood cell health, immune support, and blood circulation, helping to reduce inflammation markers.
• Methylene Blue: A powerful antioxidant that aids mitochondrial function by enhancing cellular energy (ATP) production and targeting infections.

How the Study Worked

Each participant received six IV treatments. The first session focused solely on UBI, while the second added ozone, and the third through fifth sessions included increasing amounts of methylene blue (10mg, 20mg, and 30mg, respectively). Data was collected before and after each session to track various blood markers, including inflammatory markers, kidney function, and blood stickiness levels.

Key Findings and Outcomes

Dr. Rahm highlighted several encouraging outcomes from the study:

1. Inflammation Reduction: The study found that combining UBI and ozone produced significant reductions in erythrocyte sedimentation rate (ESR), a marker of inflammation, with some participants experiencing up to 67% improvement.

2. Blood Stickiness and Fibrinogen Levels: Fibrinogen, another indicator of blood viscosity, decreased by 24% on average, indicating improved blood flow and reduced cardiovascular stress.

3. Kidney Function: Although there was a slight improvement in kidney function markers, it was less pronounced than in previous studies using only EBOO (Extracorporeal Blood Oxygenation and Ozonation). This result suggests that while UBI and ozone therapies are beneficial for inflammation, their effects on kidney function might be less impactful.

4. Mitochondrial Support: While methylene blue did not specifically reduce inflammatory markers, it plays a crucial role in enhancing mitochondrial health by boosting ATP production, which supports overall cellular energy.

Real-World Benefits of Methylene Blue, Ozone, and UBI

This study confirms that these therapies offer broad-spectrum support for various conditions—from chronic inflammation and autoimmune conditions to immune support and general wellness. For those seeking alternative solutions with potential benefits across cellular health and immune resilience, this combination shows promise. Dr. Rahm noted, however, that each therapy may affect individuals differently, with some experiencing profound symptom relief and others benefiting more subtly.

A Commitment to Ongoing Research

Dr. Rahm expressed his commitment to integrating evidence-based treatments that provide true health benefits. At Oasis, the journey to explore and validate holistic therapies is ongoing, with upcoming studies planned to assess other therapies like direct ozone and standalone UBI.

If you or someone you know could benefit from learning about these therapies, please share this information. Oasis Family Medicine aims to provide informed, research-backed care that empowers patients in their wellness journeys.

Contact Us
To learn more about these therapies or participate in future studies, contact Heidi at 818-957-6909.